Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124535032 | 12453503 | 2 | F | 2006 | 20151020 | 20160609 | 20160720 | EXP | US-DSJP-DSU-2015-121612 | DAIICHI | 0.00 | F | Y | 136.51000 | KG | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124535032 | 12453503 | 1 | PS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/25 MG 40/12.5 MG | N | 21532 | FILM-COATED TABLET | |||||||||
| 124535032 | 12453503 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40/12.5 MG | N | 21532 | FILM-COATED TABLET | |||||||||
| 124535032 | 12453503 | 3 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40-25 | N | 0 | TABLET | |||||||||
| 124535032 | 12453503 | 4 | SS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 40-12.5 | N | 0 | TABLET | |||||||||
| 124535032 | 12453503 | 5 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 6 | C | NORVASC | AMLODIPINE BESYLATE | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 7 | C | CELEBREX | CELECOXIB | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 8 | C | PRINIVIL | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 9 | C | ZESTRIL | LISINOPRIL | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 10 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 11 | C | GABAPENTIN. | GABAPENTIN | 1 | UNK, DAILY | 0 | |||||||||||
| 124535032 | 12453503 | 12 | C | NEURONTIN | GABAPENTIN | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 13 | C | TRICOR /00090101/ | ADENOSINE | 1 | UNK | 0 | |||||||||||
| 124535032 | 12453503 | 14 | C | NITROGLYCERINE | NITROGLYCERIN | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124535032 | 12453503 | 1 | Hypertension |
| 124535032 | 12453503 | 3 | Hypertension |
| 124535032 | 12453503 | 5 | Product used for unknown indication |
| 124535032 | 12453503 | 6 | Hypertension |
| 124535032 | 12453503 | 7 | Product used for unknown indication |
| 124535032 | 12453503 | 8 | Hypertension |
| 124535032 | 12453503 | 9 | Hypertension |
| 124535032 | 12453503 | 10 | Hypertension |
| 124535032 | 12453503 | 11 | Product used for unknown indication |
| 124535032 | 12453503 | 12 | Product used for unknown indication |
| 124535032 | 12453503 | 13 | Product used for unknown indication |
| 124535032 | 12453503 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124535032 | 12453503 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124535032 | 12453503 | Acute kidney injury | |
| 124535032 | 12453503 | Constipation | |
| 124535032 | 12453503 | Disability | |
| 124535032 | 12453503 | Gastrooesophageal reflux disease | |
| 124535032 | 12453503 | Malabsorption |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124535032 | 12453503 | 1 | 2003 | 20140708 | 0 | |
| 124535032 | 12453503 | 2 | 2003 | 20140708 | 0 | |
| 124535032 | 12453503 | 3 | 2003 | 20140708 | 0 | |
| 124535032 | 12453503 | 4 | 2003 | 20140708 | 0 | |
| 124535032 | 12453503 | 6 | 2014 | 0 | ||
| 124535032 | 12453503 | 8 | 2014 | 0 | ||
| 124535032 | 12453503 | 9 | 2014 | 0 | ||
| 124535032 | 12453503 | 10 | 2014 | 0 |